Application of serum anti-ENO1 and anti-SSNA1 antibody biomarkers in predicting the prognosis of gastric cancer.

Oncol Lett · 2025 · PMC12134978 · PMID 40469915

Europe PMC DOI

hedged sentences

0.2800

closest p · 5.6× alpha

0.2800

boldest claim

The sentences

a notable trendP=0.28not close (p > 0.1)

No statistically significant difference was observed in the patients' overall survival rates between the s-ENO1-Ab(+) and s-ENO1-Ab-negative (−) groups; however, the s-ENO1-Ab(+) group demonstrated a notable trend toward an improved prognosis (P=0.28; Fig. 5A ).

also in 2,380 other papers

showed a trendno p-value reported

According to the Human Protein Atlas dataset, high mRNA expression levels of ENO1 and SSNA1 showed a trend towards shorter overall survival, while low expression levels showed a trend towards longer overall survival (ENO1: P=0.07, SSNA1: P<0.05).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.